State Of Wisconsin Investment Board Bio Atla, Inc. Transaction History

State Of Wisconsin Investment Board

  • $36.9 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$1.88 - $3.46 $23,312 - $42,904
12,400 New
12,400 $42,000
Q2 2022

Aug 15, 2022
BUY
$2.13 - $5.38 $51,333 - $129,658
24,100 Added 154.49%
39,700 $113,000
Q1 2021

May 17, 2021
BUY
$32.41 - $70.91 $505,595 - $1.11 Million
15,600 New
15,600 $793,000

Others Institutions Holding BCAB

# of Institutions
70
Shares Held
23.4M
Call Options Held
30.8K
Put Options Held
57K
View Full List

About BioAtla, Inc.

BCAB Quotes by TradingView
  • Ticker BCAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,304,100
  • Market Cap $12M
  • Description
  • BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...
More about BCAB
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email